PW Medtech Group 過去の業績

過去基準チェック /46

PW Medtech Groupの収益は年間平均-17.6%の割合で減少していますが、 Medical Equipment業界の収益は年間増加しています。収益は年間14.7% 22.3%割合で増加しています。 PW Medtech Groupの自己資本利益率は4.2%であり、純利益率は21.9%です。

主要情報

-17.6%

収益成長率

-17.5%

EPS成長率

Medical Equipment 業界の成長	13.7%
収益成長率	22.3%
株主資本利益率	4.2%
ネット・マージン	21.9%
前回の決算情報	30 Jun 2024

PW Medtech Group's (HKG:1358) Solid Earnings Are Supported By Other Strong Factors

Sep 26

Recent updates

PW Medtech Group's (HKG:1358) Solid Earnings Are Supported By Other Strong Factors

Sep 26

How Much Have PW Medtech Group (HKG:1358) Shareholders Earned On Their Investment Over The Last Five Years?

Feb 18

Should You Rely On PW Medtech Group's (HKG:1358) Earnings Growth?

Jan 23

Here's Why PW Medtech Group (HKG:1358) Can Manage Its Debt Responsibly

Dec 28

Should You Be Adding PW Medtech Group (HKG:1358) To Your Watchlist Today?

Dec 10

What You Need To Know About PW Medtech Group Limited's (HKG:1358) Investor Composition

Nov 22

収支内訳

PW Medtech Group の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。

収益と収入の歴史

SEHK:1358 収益、費用、利益 ( )CNY Millions
日付	収益	収益	G+A経費	研究開発費
30 Jun 24	694	152	196	39
31 Mar 24	685	153	196	40
31 Dec 23	675	153	195	41
30 Sep 23	658	135	205	46
30 Jun 23	642	116	216	50
31 Mar 23	589	111	203	46
31 Dec 22	537	106	190	41
30 Sep 22	444	72	160	34
30 Jun 22	352	39	131	27
31 Mar 22	312	389	127	23
31 Dec 21	271	739	123	20
30 Sep 21	275	995	126	31
30 Jun 21	279	1,252	128	42
31 Mar 21	263	942	139	44
31 Dec 20	247	632	149	46
30 Sep 20	269	398	166	36
30 Jun 20	291	163	182	26
31 Mar 20	327	123	182	26
31 Dec 19	362	82	182	26
30 Jun 19	340	136	159	24
31 Mar 19	325	126	138	26
31 Dec 18	311	115	117	27
30 Jun 18	300	27	118	20
31 Mar 18	293	16	122	17
31 Dec 17	287	5	125	13
30 Sep 17	236	11	98	10
30 Jun 17	185	17	71	7
31 Mar 17	252	63	79	10
31 Dec 16	320	109	87	12
30 Jun 16	455	197	102	17
31 Mar 16	485	201	116	20
31 Dec 15	516	204	130	24
30 Sep 15	650	208	192	37
30 Jun 15	665	208	183	38
31 Mar 15	637	192	179	36
31 Dec 14	608	177	174	35
30 Sep 14	557	144	160	33
30 Jun 14	507	112	145	31
31 Mar 14	482	95	133	27
31 Dec 13	457	78	122	23

質の高い収益: 1358は高品質の収益を持っています。

利益率の向上: 1358の現在の純利益率 (21.9%)は、昨年(18.1%)よりも高くなっています。

フリー・キャッシュフローと収益の比較

過去の収益成長分析

収益動向: 1358の収益は過去 5 年間で年間17.6%減少しました。

成長の加速: 1358の過去 1 年間の収益成長率 ( 31% ) は、5 年間の平均 ( 年間-17.6%を上回っています。

収益対業界: 1358の過去 1 年間の収益成長率 ( 31% ) はMedical Equipment業界-4.3%を上回りました。

株主資本利益率

高いROE: 1358の自己資本利益率 ( 4.2% ) は低いとみなされます。

PW Medtech Group 過去の業績

過去 基準チェック /46

主要情報

最近の業績更新

PW Medtech Group's (HKG:1358) Solid Earnings Are Supported By Other Strong Factors

PW Medtech Group Limited to Report First Half, 2024 Results on Aug 30, 2024

Full year 2023 earnings released: EPS: CN¥0.098 (vs CN¥0.068 in FY 2022)

PW Medtech Group Limited to Report Fiscal Year 2023 Results on Mar 28, 2024

PW Medtech Group Limited to Report First Half, 2023 Results on Aug 31, 2023

Full year 2022 earnings released: EPS: CN¥0.068 (vs CN¥0.47 in FY 2021)

Recent updates

Upcoming dividend of HK$0.045 per share

PW Medtech Group's (HKG:1358) Solid Earnings Are Supported By Other Strong Factors

Insufficient new directors

PW Medtech Group Limited to Report First Half, 2024 Results on Aug 30, 2024

Now 21% overvalued after recent price rise

Upcoming dividend of HK$0.05 per share

Executive Chairman & CEO recently sold HK$53k worth of stock

Here's Why PW Medtech Group Limited's (HKG:1358) CEO Might See A Pay Rise Soon

PW Medtech Group Limited (SEHK:1358) announces an Equity Buyback for HKD 150 million worth of its shares.

PW Medtech Group Limited, Annual General Meeting, Jun 14, 2024

Full year 2023 earnings released: EPS: CN¥0.098 (vs CN¥0.068 in FY 2022)

PW Medtech Group Limited to Report Fiscal Year 2023 Results on Mar 28, 2024

There's Reason For Concern Over PW Medtech Group Limited's (HKG:1358) Price

Upcoming dividend of HK$0.049 per share at 11% yield

PW Medtech Group Limited Announces Interim (Semi-Annual) Dividend for the Six Months Ended 30 June 2023, Payable on October 24, 2023

PW Medtech Group Limited Announces Interim (Semi-Annual) Dividend for the Six Months Ended 30 June 2023, Payable on October 24, 2023

PW Medtech Group Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 June 2023

PW Medtech Group Limited to Report First Half, 2023 Results on Aug 31, 2023

New minor risk - Market cap size

Full year 2022 earnings released: EPS: CN¥0.068 (vs CN¥0.47 in FY 2021)

We Think PW Medtech Group (HKG:1358) Can Manage Its Debt With Ease

First half 2022 earnings released: EPS: CN¥0.039 (vs CN¥0.48 in 1H 2021)

PW Medtech Group Limited Announces Executive Changes

PW Medtech Group Limited Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2022

PW Medtech Group Limited to Report First Half, 2022 Results on Aug 31, 2022

Full year 2021 earnings: EPS and revenues miss analyst expectations

PW Medtech Group Limited, Annual General Meeting, Jun 08, 2022

Full year 2021 earnings: EPS and revenues miss analyst expectations

PW Medtech Group Limited (SEHK:1358) agreed to acquire 51.5% stake in Beijing Ruijian High-Tech Biological Technology Co., Ltd from a group of shareholders for CNY 412 million.

First half 2021 earnings released: EPS CN¥0.48 (vs CN¥0.09 in 1H 2020)

Investor sentiment improved over the past week

Independent Non-Executive Director Xingdong Zhang has left the company

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS CN¥0.40 (vs CN¥0.052 in FY 2019)

Full year 2020 earnings released: EPS CN¥0.40 (vs CN¥0.052 in FY 2019)

PW Medtech Group Limited to Report Fiscal Year 2020 Results on Mar 30, 2021

How Much Have PW Medtech Group (HKG:1358) Shareholders Earned On Their Investment Over The Last Five Years?

New 90-day low: HK$0.52

Should You Rely On PW Medtech Group's (HKG:1358) Earnings Growth?

New 90-day high: HK$2.31

CITIC Capital Holdings Limited completed the acquisition of 2.4% stake in China Biologic Products Holdings, Inc. (NasdaqGS:CBPO) from PW Medtech Group Limited (SEHK:1358).

Here's Why PW Medtech Group (HKG:1358) Can Manage Its Debt Responsibly

Should You Be Adding PW Medtech Group (HKG:1358) To Your Watchlist Today?

New 90-day high: HK$2.29

What You Need To Know About PW Medtech Group Limited's (HKG:1358) Investor Composition

Market bids up stock over the past week

CITIC Capital Holdings Limited entered into an agreement to acquire 2.4% stake in China Biologic Products Holdings, Inc. (NasdaqGS:CBPO) from PW Medtech Group Limited (SEHK:1358) for approximately $110 million.

New 90-day high: HK$1.76

First half earnings released

PW Medtech Group Limited to Report First Half, 2020 Results on Aug 27, 2020

収支内訳

収益と収入の歴史

フリー・キャッシュフローと収益の比較

過去の収益成長分析

株主資本利益率

総資産利益率

使用総資本利益率

過去の好業績企業の発掘

過去基準チェック /46